# Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)

> **NCT02728778** · PHASE2 · COMPLETED · sponsor: **Hannover Medical School** · enrollment: 54 (actual)

## Conditions studied

- Borderline Personality Disorder

## Interventions

- **DRUG:** incobotulinumtoxin A
- **PROCEDURE:** Acupuncture

## Key facts

- **NCT ID:** NCT02728778
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-10-31
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02728778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02728778, "Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02728778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*